Muhammad J Tariq » Division of Hematology & Oncology » College of Medicine

About Muhammad J Tariq

I was drawn to hematology-oncology for its rich creativity and rapidly evolving science. After receiving my medical degree in 2016 from King Edward Medical University in Lahore, Pakistan, I completed a residency in internal medicine at the John H. Stroger, Jr. Hospital in Chicago. I then completed a fellowship in hematology and medical oncology at the University of Buffalo’s Roswell Park Comprehensive Cancer Center.

The continuous advancements in cancer treatment not only make the field exciting but also allow me to provide meaningful care for my patients. Caring for patients is a profound privilege, and my goal is to help develop treatments that not only aim to cure cancer but also preserve and enhance patients’ quality of life. I believe effective care should support patients in living fully, with dignity, purpose and as few side effects as possible. I want every future patient to know that I will always prioritize their well-being as if they were my own family. I will advocate for the safest, most effective treatments while ensuring they feel heard, respected and fully informed.

In my free time, I enjoy connecting with my family, reading and exploring outdoor parks and gardens. These activities provide balance in my life and foster personal growth.

Teaching Profile

Courses Taught

BMS6631 – Hematology

2026 College of Medicine

Board Certifications

Hematology

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology

American Board of Internal Medicine

Clinical Profile

Specialties

Cancer
Hematology and Oncology

Areas of Interest

Bone Marrow Transplant
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia (CLL)
Hodgkin Lymphoma
Non-Hodgkin Lymphoma

Research Profile

Areas of Interest

CAR-T cell therapy
Chronic Lymphocytic Leukemia (CLL)
Lymphoplasmacytic Lymphoma / Waldenström Macroglobulinemia
Non-Hodgkin Lymphoma

Publications

Academic Articles

Grants

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study Evaluating the Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With Multiple Myeloma – The GENESIS Study

July 30, 2018 Active

Role:

Principal Investigator

Funding:

BIOLINE RX

Education

Fellowship, Hematology and Medical Oncology

2022-2025 Roswell Park Comprehensive Cancer Center
Residency, Internal Medicine

2019-2022 John H Stroger Jr Hospital of Cook County
Medical Degree

2011-2016 King Edward Medical University